by Eric Christianson | May 13, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Selective serotonin reuptake inhibitors (SSRIs) are among the most frequently prescribed medication classes in clinical practice. While they are generally considered safe and effective, clinicians should remain aware of several important drug interactions that can...
by Eric Christianson | May 10, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Seasonal affective disorder (SAD) presents a unique opportunity in psychiatric prescribing because, unlike many other mood disorders, the timing of symptoms is often predictable. Patients typically experience depressive symptoms during the fall and winter months, with...
by Eric Christianson | May 6, 2026 | Polypharmacy Cases And The Prescribing Cascade
If I had 60 seconds to review a med list, I wouldn’t try to analyze every detail. That’s the biggest mistake clinicians make when time is limited. Instead, I rely on pattern recognition—quickly scanning for a handful of high-yield problem areas that consistently lead...
by Eric Christianson | May 3, 2026 | Polypharmacy Cases And The Prescribing Cascade
I’ve been collecting examples of situations where a patient is “stable”, and a provider doesn’t want to change medications. Stable is good, right? It is, but it can also lead to providers not wanting to reduce medications and change anything....
by Eric Christianson | Apr 29, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Clonidine and guanfacine are both alpha-2 adrenergic agonists used in the treatment of ADHD, but they behave differently enough in clinical practice that they are not truly interchangeable. In this article, we will compare and contrast clonidine versus guanfacine in...
